KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Accured Expenses: 2017-2025

Historic Change in Accured Expenses for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $6.6 million.

  • Twist Bioscience's Change in Accured Expenses fell 41.59% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 16.04%. This contributed to the annual value of $6.6 million for FY2025, which is 16.04% down from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Change in Accured Expenses is $6.6 million, which was down 16.04% from $7.9 million recorded in FY2024.
  • Twist Bioscience's 5-year Change in Accured Expenses high stood at $7.9 million for FY2024, and its period low was -$7.4 million during FY2022.
  • For the 3-year period, Twist Bioscience's Change in Accured Expenses averaged around $5.7 million, with its median value being $6.6 million (2025).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 200.43% in 2022, then spiked by 205.47% in 2024.
  • Twist Bioscience's Change in Accured Expenses (Yearly) stood at $7.4 million in 2021, then tumbled by 200.43% to -$7.4 million in 2022, then skyrocketed by 134.73% to $2.6 million in 2023, then spiked by 205.47% to $7.9 million in 2024, then decreased by 16.04% to $6.6 million in 2025.